NRXP

NRx Pharmaceuticals (NRXP)

About NRx Pharmaceuticals (NRXP)

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.

Details

Daily high

$2.14

Daily low

$1.96

Price at open

52 Week High

$6.01

52 Week Low

$1.40

Market cap

59.0M

Dividend yield

0.00%

Volume

328

Avg. volume

444,332

P/E ratio

-.89

NRx Pharmaceuticals News